Table 1 The demographic and clinical characteristics of the study participants

Age, year

3.1 (0.9–4.8)

2.7 (1.1–4.8)

3.0 (0.8–5.1)

Sex, Female/Male

8/10

3/6

7/8

WBC, 10⁹/L

15.6 (6.99–33.2) ^†,‡

7.25 (5.71–10.82)

7.69 (5.1–9.83)

Neutrophils, 10⁹/L

10.35 (1.2–30.8) ^†,‡

3.18 (1.96–5.5)

2.82 (2.51–5.02)

Lymphocytes, 10⁹/L

3.36 (1.3–8.9)

2.97 (1.87–3.91)

4.06 (1.03–5.3)

CRP, mg/L

49 (12.71–186)^†,‡

11.5 (3.28–17.1) ^†

1.7 (0.5–3.8)

ESR, mm/h

75 (12–110) ^†

79 (15–99) ^†

6 (2–19)

IgG, g/L

6.485 (1.83–16.3)

ND

5.93 (2.12–10.72)

IgA, g/L

0.83 (0.11–1.29)

ND

0.92 (0.5–2.4)

IgM, g/L

1.045 (0.18–1.77)

ND

1.115 (0.2–1.63)

C3, g/L

1.26 (0.72–2.07)

1.1 (0.63–1.98)

1.32 (0.63–1.8)

C4, g/L

0.275 (0.16–0.51)

0.26 (0.16–0.5)

0.235 (0.18–0.49)